Auteur N. FOUILHE

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Addictovigilance contribution during COVID-19 epidemic and lockdown in France

M. LAPEYRE-MESTRE ; A. BOUCHER ; A. DAVELUY ; V. GIBAJA ; E. JOUANJUS ; M. MALLARET ; H. PEYRIERE ; J. MICALLEF ; E. BOUQUET ; L. CHAOUACHI ; C. CHEVALLIER ; S. DEHEUL ; C. EIDEN ; N. FOUILHE ; C. FOURNIER-CHOMA ; E. FRAUGER ; M. GUERLAIS ; R. LE BOISSELIER ; G. MIREMONT ; A. ROUSSIN ; J. TOURNEBIZE ; French Addictovigilance Network | 2020
Dans Therapies (Vol.75, n°4, Juillet-Août 2020) Article : Périodique

Addictovigilance is a safety monitoring targeted at substances with potential for abuse and dependence. This vigilance was involved during the period of COVID-19 epidemic due to the significant changes in access to drugs and psychological disrup[...]

Plus d'info

Ajouter à la sélection

Lien externe

Alprazolam misuse: Analysis of French Addictovigilance Network data from 2011 to 2020

L. DIAZ ; C. EIDEN ; E. JOUANJUS ; E. FRAUGER ; N. FOUILHE ; S. DJEZZAR ; V. GIBAJA ; A. BOUCHER ; R. LE BOISSELIER ; F. LIBERT ; A. S. CAOUS ; E. MONZON ; M. GUERLAIS ; A. DAVELUY ; B. FAUCONNEAU ; H. PEYRIERE | 2023
Dans Therapies (Vol.78, n°6, Novembre-Décembre 2023) Article : Périodique

Objectives: Alprazolam, a high-potency and short-acting anxiolytic benzodiazepine, is one of the most misused benzodiazepines in France. In the context of various reports on alprazolam misuse during the COVID-19 pandemic, the objective of this s[...]

Plus d'info

Ajouter à la sélection

Lien externe

Gabapentinoid abuse in France: Evidence on health consequences and new points of vigilance

M. TAMBON ; C. PONTÉ ; E. JOUANJUS ; N. FOUILHE ; J. MICALLEF ; M. LAPEYRE-MESTRE ; French Addictovigilance Network | 2021
Dans Frontiers in Psychiatry (Vol.12, 2021) Article : Périodique

Introduction: Gabapentinoid drugs (gabapentin and pregabalin) are widely used worldwide for epileptic and pain disorders. First signals of gabapentinoid abuse occurred in the last decade. This study aims to describe clinical characteristics of g[...]

Plus d'info

Ajouter à la sélection

Lien externe

Health consequences of cocaine use in France: data from the French addictovigilance network

C. EIDEN ; M. VINCENT ; C. SERRAND ; A. SERRE ; N. RICHARD ; M. C. PICOT ; E. FRAUGER ; N. FOUILHE ; A. DAVELUY ; H. PEYRIERE ; French Addictovigilance Network | 2021
Dans Fundamental and Clinical Pharmacology (Vol.35, n°2, April 2021) Article : Périodique

ENGLISH: As the number and severity of complications related to cocaine use reported to the French Addictovigilance network have increased, the French health authorities requested a national epidemiologic study of the data collected by this net[...]

Plus d'info

Ajouter à la sélection

Increase of high-risk tramadol use and harmful consequences in France from 2013-2018: evidence from the triangulation of addictovigilance data

A. ROUSSIN ; T. SOEIRO ; C. FOUQUE ; E. JOUANJUS ; E. FRAUGER ; N. FOUILHE ; M. MALLARET ; J. MICALLEF ; M. LAPEYRE-MESTRE ; French Addictovigilance Network | 2022
Dans British Journal of Clinical Pharmacology (Vol.88, n°8, August 2022) Article : Périodique

AIM: To assess recent developments in non-medical tramadol use, tramadol use disorder, illegal procurement, and deaths. METHODS: Repeated cross-sectional analysis of data collected nationwide from 2013-2018. Analysis through the multisource mon[...]

Plus d'info

Ajouter à la sélection

Lien externe